Changeflow GovPing Healthcare & Life Sciences Biomolecule Retention Patent, 11 Inventors, Pub...
Routine Notice Added

Biomolecule Retention Patent, 11 Inventors, Published Apr 23

Email

Summary

Biomolecule Retention Patent, 11 Inventors, Published Apr 23

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 242 changes logged to date.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION

Application US20260109974A1 Kind: A1 Apr 23, 2026

Inventors

Torri Elise RINKER, Christina INMAN, Parag MALLICK, Tural AKSEL, Stephen HENDRICKS, Pierre INDERMUHLE, Hongji QIAN, Steven TAN, Elvis IKWA, Pengyu HAO, Sadie INGLE

Abstract

Compositions, systems, and methods for the display of analytes such as biomolecules are described. Display of analytes is achieved by coupling of the analytes to displaying molecules that are configured to associate with surfaces or interfaces. Arrays of analytes may be formed from the described systems for utilization in assays and other methods.

CPC Classifications

C12N 15/1093 B01J 19/0046 B82Y 5/00 C12Q 1/6804 C12Q 1/6837 B01J 2219/0061

Filing Date

2025-12-22

Application No.

19429409

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!